Skip to main content
logo
Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
3.650
+0.020 (0.55%)
At close: Jul 30, 2026, 4:00 PM EDT
3.556
-0.094 (-2.59%)
After-hours: Jul 30, 2026, 7:34 PM EDT

Plus Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.185.215.824.910.22-
Revenue Growth
-0.46%-10.49%18.54%2093.30%--
Gross Profit
5.185.215.824.910.22-
Operating Income
-18.88-15.3-14.7-13.32-19.71-12.43
Net Income
-10.97-22.39-12.98-13.32-20.28-13.4
Earnings Per Share
-2.30-7.25-58.50-106.00-289.50-415.75
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
15.1113.113.618.5518.1218.4
Total Debt
0.730.823.374.15.56.99
Net Cash (Debt)
14.3912.290.244.4612.6211.41
Net Cash Growth
46.42%5043.52%-94.64%-64.66%10.60%738.75%
Net Cash Per Share
2.243.950.7835.48180.19353.84

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-20.84-20.78-10.55-12.85-12.97-12.85
Capital Expenditures
-0.88-0.07-0.15---0.16
Free Cash Flow
-21.72-20.84-10.7-12.85-12.97-13.01
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-364.36%-293.46%-252.32%-271.14%-8800.00%-
Pretax Margin
-211.71%-429.43%-222.84%-271.04%-9051.34%-
Profit Margin
-211.71%-429.43%-222.84%-271.04%-9051.34%-
FCF Margin
-419.20%-399.81%-183.72%-261.57%-5791.07%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-2.562.562.562.562.56
PS Ratio
4.8513.631.161.6148.00-